logo
Select company
Select metric
$ -15.72MConsolidated Income
VS
Market
31
Sector
60
Industry
54
History
3
$ 3.94Close
$ 2.13 - $ 4.11 52-Week Range
Ticker Information

Ticker

AIMD

Company Name

AINOS INC

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ

AINOS INC - Consolidated Income Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

AIMD - Cons. Inc. Historical data
DateConsolidated Income
6/30/2025$ -15.72M
3/31/2025$ -14.83M
12/31/2024$ -14.86M
9/30/2024$ -16.13M
6/30/2024$ -15.41M
3/31/2024$ -14.56M
12/31/2023$ -13.77M
9/30/2023$ -9.98M
6/30/2023$ -14.82M
3/31/2023$ -14.43M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • AINOS INC's latest trailing twelve months (TTM) Cons. Inc. stands at $ -1.37M.
  • Over the past 5 years, AINOS INC's average Cons. Inc. has been $ -9.86M.
  • The median Cons. Inc. for AINOS INC during this period was $ -13.55M
  • AINOS INC reached its highest Cons. Inc. over the past 5 years at $ -1.37M.
  • The lowest Cons. Inc. recorded by AINOS INC in the same timeframe $ -16.13M

AINOS INC's Cons. Inc. vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cons. Inc. Benchmarks
CompanyCons. Inc.
PFSA : PROFUSA INC $ -18.93MNXL : NEXALIN TECHNOLOGY INC $ -8.85MSABS : SAB BIOTHERAPEUTICS INC $ -37.06MAIM : AIM IMMUNOTECH INC $ -16.17MHSCS : HEARTSCIENCES INC $ -8.77MBFRG : BULLFROG AI HOLDINGS INC $ -6.94MSILO : SILO PHARMA INC $ -4.9MHCWB : HCW BIOLOGICS INC $ -11.4MVIVS : VIVOSIM LABS INC $ -1.99MMTVA : METAVIA INC $ -18.49M

Definition of Consolidated Income

[Income Statement] The portion of profit or loss for the period; net of income taxes; which is attributable to the consolidated entity; before the deduction of [NetIncNCI].

AIMD - Consolidated Income, Last 5 years

$ -16.13M

Minimum

Sep 30, 2024

$ -1.37M

Maximum

Sep 30, 2020

$ -9.86M

Average

$ -13.55M

Median

Cons. Inc. Benchmark Analysis

The chart above depicts the distribution of Cons. Inc. for companies in the Total Stock Market. The average Cons. Inc. of the companies is $ 12.09M with a standard deviation of $ 116.52M.
The following table provides additional summary stats:
Cons. Inc. in the Market:
filtered constituents3.36K
min$ -363.1M
max$ 377.69M
average$ 12.09M
median$ -2.07M
std$ 116.52M